37th Session of the WHO Expert Committee on Drug Dependence

News

37th Session of the WHO Expert Committee on Drug Dependence

6 December 2015

The WHO Expert Committee on Drug Dependence met on 16th November at the occasion of its 37th Session. A series of presentations were made in this occasion, a list of which is available below. The presentations and statements included a submission from Christiphor Hallam, Research and Analysis Officer at the International Drug Policy Consortium.

  • Ketamine and international control, Christopher Hallam, Research and Analysis, International Drug Policy Consortium
  • Global Benefit Versus Harm of Ketamine, Dr Thomas Burke, Chief, Division of Global Health and Human Rights, Massachusetts General Hospital Associate Professor, Harvard Medical School, Center for African Studies, Harvard University
  • The impact of ketamine on global surgery, Dr Walt Johnson, Emergency and Essential Surgical Care Programme Lead, WHO
  • Role of ketamine in the work of Médecins Sans Frontières and the International Committee of the Red Cross, Mr Christophe Perrin, Pharmaceutical Coordinator, Médecins Sans Frontières
  • Protecting ketamine as an essential medicine, Dr Jason Nickerson, Bruyère Research Institute
  • The veterinary profession position statement in opposition to the international scheduling of ketamine, Dr René Carlson, President, World Veterinary Association
  • Statement on ketamine, Prof. Walid Habre, World Federation of Societies of Anaesthesiologists and European Society of Anaesthesiology
  • Global Patient Populations Need International Medical Cannabis Policies to Evolve, Steph Sherer, Executive Director, Americans for Safe Access

Click here to read the submissions.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert

Thumbnail: Flickr CC John and Melanie

Regions

Related Profiles

  • World Health Organization (WHO)
  • International Drug Policy Consortium (IDPC)
  • Christopher Hallam